| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
From the Departments of Epidemiology (GF-M, AN-A, and EG) and Environmental Health Sciences (AN-A), Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD; the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD (GF-M, AN-A, and EG); the Department of Preventive Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain (GF-M); and the Division of Biostatistics, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain (RP-B)
Background:It is hypothesized that low selenium concentrations are associated with an increased risk of cardiovascular disease and that selenium supplements prevent coronary heart disease.
Objective:The objective was to perform a meta-analysis on the association of selenium biomarkers with coronary heart disease endpoints in observational studies and on the efficacy of selenium supplements in preventing coronary heart disease endpoints in randomized trials.
Design:The MEDLINE and the Cochrane Library databases were searched for studies conducted from 1966 through 2005. Relative risks were pooled by using an inverse-variance weighted random-effects model.
Results:Twenty-five observational studies (14 cohort and 11 case-control studies) that measured blood or toenail selenium concentrations and 6 randomized trials that evaluated supplements containing selenium met our inclusion criteria. The pooled relative risk in a comparison of the highest with the lowest selenium concentration categories was 0.85 (95% CI: 0.74, 0.99) in cohort studies and 0.43 (0.29, 0.66) in case-control studies. In observational studies, a 50% increase in selenium concentrations was associated with a 24% (7%, 38%) reduction in coronary heart disease risk. In randomized trials, the pooled relative risk in a comparison of supplements containing selenium with placebo was 0.89 (0.68, 1.17).
Conclusions:Selenium concentrations were inversely associated with coronary heart disease risk in observational studies. Because observational studies have provided misleading evidence for other antioxidants, the validity of this association is uncertain. Few randomized trials have addressed the cardiovascular efficacy of selenium supplementation, and their findings are still inconclusive. Evidence from large ongoing trials is needed to establish low selenium concentrations as a cardiovascular disease risk factor. Currently, selenium supplements should not be recommended for cardiovascular disease prevention.
Key Words: Selenium • coronary heart disease • atherosclerosis • meta-analysis • systematic review
This article has been cited by other articles:
|
|
 |
|
  W. Manati, F. Vaillant, M. Bost, V. Maffre, D. Belhani, J. Descotes, A. Tabib, B. Bui-Xuan, L. Hamdan, and Q. Timour Protective role of selenium supplementation against cardiac lesions induced by the combination of levomepromazine and risperidone in the rabbit Human and Experimental Toxicology, August 1, 2009; 28(8): 461 - 467. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Laclaustra, A. Navas-Acien, S. Stranges, J. M. Ordovas, and E. Guallar Serum Selenium Concentrations and Hypertension in the US Population Circ Cardiovasc Qual Outcomes, July 1, 2009; 2(4): 369 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bleys, A. Navas-Acien, M. Laclaustra, R. Pastor-Barriuso, A. Menke, J. Ordovas, S. Stranges, and E. Guallar Serum Selenium and Peripheral Arterial Disease: Results From the National Health and Nutrition Examination Survey, 2003-2004 Am. J. Epidemiol., April 15, 2009; 169(8): 996 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Seyyed Mohammad Reza Parizadeh, M. Moohebati, F. Ghafoori, M. Ghayour-Mobarhan, Seyyed Mohammad Reza Kazemi-Bajestani, S. Tavallaie, M. Azimi-Nezhad, and G. A. Ferns Serum Selenium and Glutathione Peroxidase Concentrations in Iranian Patients With Angiography-Defined Coronary Artery Disease Angiology, April 1, 2009; 60(2): 186 - 191. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Chung, E. M Balk, S. Ip, G. Raman, W. W Yu, T. A Trikalinos, A. H Lichtenstein, E. A Yetley, and J. Lau Reporting of systematic reviews of micronutrients and health: a critical appraisal Am. J. Clinical Nutrition, April 1, 2009; 89(4): 1099 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Hawkes and L. J. Laslett Selenium supplementation does not improve vascular responsiveness in healthy North American men Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H256 - H262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bleys, A. Navas-Acien, S. Stranges, A. Menke, E. R Miller III, and E. Guallar Serum selenium and serum lipids in US adults Am. J. Clinical Nutrition, August 1, 2008; 88(2): 416 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Boosalis The Role of Selenium in Chronic Disease Nutr Clin Pract, April 1, 2008; 23(2): 152 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bleys, A. Navas-Acien, and E. Guallar Serum Selenium Levels and All-Cause, Cancer, and Cardiovascular Mortality Among US Adults Arch Intern Med, February 25, 2008; 168(4): 404 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stranges, J. R. Marshall, R. Natarajan, R. P. Donahue, M. Trevisan, G. F. Combs, F. P. Cappuccio, A. Ceriello, and M. E. Reid Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes: A Randomized Trial Ann Intern Med, August 21, 2007; 147(4): 217 - 223. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
